According to aTyr Pharma's latest financial reports the company's current EPS (TTM) is -$1.23. In 2022 the company made an earnings per share (EPS) of -$1.60 an increase over its 2021 EPS that were of -$1.88.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.23 | -23.13% |
2022 | -$1.60 | -14.89% |
2021 | -$1.88 | 18.24% |
2020 | -$1.59 | -78.37% |
2019 | -$7.35 | -54.6% |
2018 | -$16.19 | -38.81% |
2017 | -$26.46 | -22.54% |
2016 | -$34.16 | 5.07% |
2015 | -$32.51 | -5.55% |
2014 | -$34.42 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Vertex Pharmaceuticals VRTX | $13.09 | -1,164.23% | ๐บ๐ธ USA |
![]() Veracyte VCYT | -$0.40 | -67.48% | ๐บ๐ธ USA |